Order:
Careers Media center Contacts

CLARITHROMYCIN




Active substance: сlarithromycin

ATC: J01FA09

How supplied: Tablets

Dosage form
Tablets 0.25 g №10 or 0.5 g №10.

Active ingredient
1 tablet contains clarithromycin, calculated on 100 % basis – 250 mg or 500 mg.

Indications
Treatment of infections causes by microorganisms, which are sensitive to clarithromycin: infections of the upper respiratory tract, i.e. nose and throat (tonsillitis, pharyngitis) and infections of the sinuses; lower respiratory tract infections (e.g. bronchitis, acute lobar pneumonia, primary atypical pneumonia); infections of the skin and soft tissues (such as impetigo, folliculitis, erysipeloid, abrasions, infected wounds); acute and chromin odontogenic infection; disseminated or localized mycobacterial infections caused by Mycobacterium avium and Mycobacteriym intracellulare. Localized infection caused by Mycobacterium chelonae, Mycobacterium fortuitum and Mycobacterium kansasii; eradication of H. pylori in patients with duodenal ulcer in inhibition of acid secretion (clarithromycin activity against H. pylori at neutral pH is higher than acidic pH).

ATTENTION!

The following information is intended for medical and pharmaceutical professionals only and can be used exclusively in professional activities.

ARE YOU A MEDICAL AND/OR PHARMACEUTICAL PROFESSIONAL?

(submitting the answer, you bear full responsibility for the accuracy of the information provided)


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form